- Anaesthesia, Perioperative Medicine, and Critical Care
- Ear, Nose and Throat
- Infectious Diseases
- Mental Health
- Metabolic and Endocrine
- Musculoskeletal Health
- Neuroprogressive and Dementia
- Oral and Dental
- Primary Care
- Regenerative Medicine
- Reproductive Health and Childbirth
- Trauma and Emergencies
Prof David Cameron
Prof. Cameron received his medical degree in 1986 from St. George’s Hospital Medical School, London. After completing a fellowship and MSc in Clinical Oncology at the University of Edinburgh, he received a M.D. with distinction in 1997 and completed his training as a medical oncologist that same year. Prof. Cameron has been a member of the EORTC task force on the use of growth factors in chemotherapy for solid tumours and lymphoma and a past chairman of the EORTC New Agent Committee. He is a past member of the Scottish medicines Consortium project and the Scottish short-life working group on the use of unlicensed cancer medicines.
Prof Cameron is very active in clinical trials where he is a member of the steering group for a number of UK adjuvant breast cancer trials He is also chief investigator on several UK trials adjuvant breast cancer.
Prof Cameron is a previous Director of the NIHR-funded National Cancer Research Networks, and at the end of 2009 took up a new post as Professor of Oncology at Edinburgh University and Director of Cancer Services in NHS Lothian. In this role he is the clinical director of the Edinburgh Cancer Research Centre, and has responsibility for oversight and strategy of clinical and translational research in cancer in Edinburgh. In 2014 Prof Cameron was appointed as the Chief Scientist’s Office Clinical Cancer Research Champion in Scotland to act as a focal point for current and future clinical research in cancer in Scotland.
Nodal Clinical Leads
West: Iain MacPherson
Dr Iain Macpherson trained in medicine at the University of Glasgow. After graduating he then completed a PhD at the Beatson Institute for Cancer Research and trained in Medical Oncology at the Beatson West of Scotland Cancer Centre. In 2010 he was appointed Clinical Senior Lecturer in the Institute of Cancer Sciences, University of Glasgow and Honorary Consultant in Medical Oncology at the Beatson West of Scotland Cancer Centre where he specialises in the treatment of breast cancer.
He is Principal Investigator for a number of clinical trials in breast cancer and also has an active preclinical research programme, conducted in collaboration with Prof Jim Norman at the CRUK Beatson Institute. He is Chair of the Scottish Cancer Trials Breast Group, and is a member of the NCRI Breast Clinical Studies Group and the Breast Cancer Now Scientific Advisory Board. He is also an expert member of the West of Scotland Research Ethics Committee.
South East: Ewan Brown
Dr Ewan Brown undertook his medical oncology training in Edinburgh, completed a clinical fellowship in Toronto, Canada and then completed a PhD with the University of Edinburgh. He is currently clinical lead for oncology trials at the Edinburgh Cancer Centre and local principal investigator for several clinical trials in colorectal cancer and melanoma. His major ongoing interests include clinical and translational research in melanoma and colorectal cancer, on-line education and the development of a cancer partnership with Queen Elizabeth Central Hospital, Malawi. His work is supported by a National Research Scotland (NRS) Career Researcher Award (2013-2018) and a Scottish Government Grant (2013-2018).
East: Ghulam Nabi
Clinical academic in urology trained in Surgery and Urology in India, East of Scotland Training Programme in Urology, France and Germany. Previously Clinical Lecturer at the University of Aberdeen, Professor Nabi was appointed to Chair in October 2015. Besides heading the academic section of Urology at the University of Dundee, Professor Nabi is lead for prostate cancer Surgery in Tayside and chair of Tayside Urological Cancers Network. He introduced a number of minimally invasive surgical techniques for Tayside including laparoscopic surgery in prostate cancer, single port surgery and cryoablation for renal cancers. Professor Nabi is both a chief investigator and a principal investigator for urological cancers.